Human Monoclonal Antibodies against Pseudomonas aeruginosa Lipopolysaccharide Derived from Transgenic Mice Containing Megabase Human Immunoglobulin Loci Are Opsonic and Protective against Fatal Pseudomonas Sepsis

Pseudomonas aeruginosa is a significant human pathogen, and no vaccine is commercially available. Passive antibody prophylaxis using monoclonal antibodies (MAb) against protective P. aeruginosa epitopes is an alternative strategy for preventing P. aeruginosa infection, but mouse MAb are not suitable...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Hemachandra, Sonali, Kamboj, Kulwant, Copfer, Janna, Pier, Gerald, Green, Larry L., Schreiber, John R.
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2001
Assuntos:
Microbial Immunity and Vaccines
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC98149/
https://ncbi.nlm.nih.gov/pubmed/11254577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.69.4.2223-2229.2001
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares